001     138903
005     20240605120502.0
024 7 _ |a 10.1186/s13073-016-0380-2
|2 doi
024 7 _ |a pmid:27887638
|2 pmid
024 7 _ |a pmc:PMC5124262
|2 pmc
024 7 _ |a altmetric:14124516
|2 altmetric
037 _ _ |a DZNE-2020-05225
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Klopstock, Thomas
|0 P:(DE-2719)2810704
|b 0
|e First author
|u dzne
245 _ _ |a Mitochondrial replacement approaches: challenges for clinical implementation.
260 _ _ |a London
|c 2016
|b BioMed Central
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2016-11-25
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2016-12-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1717572973_16012
|2 PUB:(DE-HGF)
|x Editorial
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The advent of mitochondrial replacement techniques poses many scientific, regulatory, and ethical questions. Previous studies suggest good safety and efficacy profiles of these techniques, but challenges remain for clinical implementation and international consensus is needed on the regulation of these approaches.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a DNA, Mitochondrial
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a DNA, Mitochondrial: genetics
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Fertilization in Vitro: ethics
|2 MeSH
650 _ 2 |a Genes, Mitochondrial
|2 MeSH
650 _ 2 |a Haplorhini
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Inheritance Patterns
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Mitochondria: genetics
|2 MeSH
650 _ 2 |a Mitochondria: transplantation
|2 MeSH
650 _ 2 |a Mitochondrial Diseases: genetics
|2 MeSH
650 _ 2 |a Mitochondrial Diseases: pathology
|2 MeSH
650 _ 2 |a Mitochondrial Diseases: prevention & control
|2 MeSH
650 _ 2 |a Mitochondrial Replacement Therapy: ethics
|2 MeSH
650 _ 2 |a Mitochondrial Replacement Therapy: methods
|2 MeSH
650 _ 2 |a Oocytes: metabolism
|2 MeSH
650 _ 2 |a Oocytes: pathology
|2 MeSH
650 _ 2 |a Spermatozoa: cytology
|2 MeSH
650 _ 2 |a Spermatozoa: metabolism
|2 MeSH
650 _ 2 |a Spindle Apparatus: genetics
|2 MeSH
650 _ 2 |a Spindle Apparatus: transplantation
|2 MeSH
700 1 _ |a Klopstock, Barbara
|b 1
700 1 _ |a Prokisch, Holger
|b 2
773 1 8 |a 10.1186/s13073-016-0380-2
|b : Springer Science and Business Media LLC, 2016-11-25
|n 1
|p 126
|3 journal-article
|2 Crossref
|t Genome Medicine
|v 8
|y 2016
|x 1756-994X
773 _ _ |a 10.1186/s13073-016-0380-2
|g Vol. 8, no. 1, p. 126
|0 PERI:(DE-600)2484394-5
|n 1
|q 8:1<126
|p 126
|t Genome medicine
|v 8
|y 2016
|x 1756-994X
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/138903/files/DZNE-2020-05225.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/138903/files/DZNE-2020-05225.pdf?subformat=pdfa
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124262
909 C O |o oai:pub.dzne.de:138903
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810704
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2016
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GENOME MED : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b GENOME MED : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 1 _ |0 I:(DE-2719)1111016
|k AG Levin
|l Clinical Neurodegeneration
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1111016
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1093/humrep/des439
|2 Crossref
|o 10.1093/humrep/des439
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature18303
|2 Crossref
|o 10.1038/nature18303
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.cmet.2016.06.012
|2 Crossref
|o 10.1016/j.cmet.2016.06.012
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature11647
|2 Crossref
|o 10.1038/nature11647
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature14546
|2 Crossref
|o 10.1038/nature14546
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.tig.2016.04.006
|2 Crossref
|o 10.1016/j.tig.2016.04.006
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.fertnstert.2014.10.028
|2 Crossref
|o 10.1016/j.fertnstert.2014.10.028
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature.2016.19290
|2 Crossref
|o 10.1038/nature.2016.19290
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature.2016.20698
|2 Crossref
|o 10.1038/nature.2016.20698
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature.2016.20849
|2 Crossref
|o 10.1038/nature.2016.20849


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21